AEPCX
Price
$62.77
Change
+$0.52 (+0.84%)
Updated
Oct 3 closing price
Net Assets
138.77B
LMGPX
Price
$80.53
Change
+$0.40 (+0.50%)
Updated
Oct 3 closing price
Net Assets
7.38B
Interact to see
Advertisement

AEPCX vs LMGPX

Header iconAEPCX vs LMGPX Comparison
Open Charts AEPCX vs LMGPXBanner chart's image
American Funds EUPAC C
Price$62.77
Change+$0.52 (+0.84%)
VolumeN/A
Net Assets138.77B
ClearBridge International Growth IS
Price$80.53
Change+$0.40 (+0.50%)
VolumeN/A
Net Assets7.38B
AEPCX vs LMGPX Comparison Chart in %
View a ticker or compare two or three
VS
AEPCX vs. LMGPX commentary
Oct 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPCX is a Buy and LMGPX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEPCX has more cash in the bank: 139B vs. LMGPX (7.38B). LMGPX pays higher dividends than AEPCX: LMGPX (1.22) vs AEPCX (0.16). AEPCX was incepted earlier than LMGPX: AEPCX (25 years) vs LMGPX (7 years). AEPCX (1.57) is less costly to investors than LMGPX (0.70). LMGPX is a more actively managed with annual turnover of: 49.00 vs. AEPCX (35.00). AEPCX has a lower initial minimum investment than LMGPX: AEPCX (250) vs LMGPX (1000000). LMGPX annual gain was more profitable for investors over the last year : 18.22 vs. AEPCX (10.37). LMGPX return over 5 years is better than : 41.72 vs. AEPCX (13.86).
AEPCXLMGPXAEPCX / LMGPX
Total Expense Ratio1.570.70224%
Annual Report Gross Expense Ratio1.570.70224%
Fund Existence25 years7 years-
Gain YTD21.48224.58287%
Front LoadN/AN/A-
Min. Initial Investment25010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets139B7.38B1,883%
Annual Yield % from dividends0.161.2213%
Returns for 1 year10.3718.2257%
Returns for 3 years42.8265.9965%
Returns for 5 years13.8641.7233%
Returns for 10 years39.95N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TVRD40.232.86
+7.65%
Tvardi Therapeutics Inc
OACCU10.65N/A
N/A
Oaktree Acquisition Corp III Life Sciences
GNTA3.30-0.01
-0.25%
Genenta Science SpA
IMCR34.21-1.08
-3.06%
Immunocore Holdings plc
IDCC339.10-17.00
-4.77%
InterDigital